About this item
Product details
Abeticolic 5 mg from Jenner Pharma contains Obeticholic Acid, a targeted farnesoid X receptor (FXR) agonist specifically developed for the treatment of Primary Biliary Cholangitis (PBC). This 5 mg strength serves as the recommended starting dose for managing this chronic autoimmune liver disease. It is used either in combination with ursodeoxycholic acid (UDCA) for patients with an inadequate response to UDCA, or as monotherapy for those intolerant to UDCA, working to protect liver cells from toxic bile acids. Targeted Liver Protection: Works through the FXR pathway to reduce liver exposure to harmful bile acids, helping to slow disease progression. Dual Therapy Foundation: Serves as the base for combination therapy with UDCA or as standalone treatment when UDCA is not tolerated. Improves Liver Parameters: Aims to reduce elevated alkaline phosphatase (ALP) levels, a key biomarker of PBC disease activity. Specialized PBC Treatment: Provides a targeted therapeutic option specifically for this chronic liver condition. Composition Each film coated tablet contains: Obeticholic Acid: 5 mg Suggested Usage As directed by the physician
- Medicines
- 30 Film Coated Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Jenner Pharma
- SKU
- 08961101920418
- Variant
- 30 Film Coated Tablets
- Tags
- Medicine, Obeticholic Acid
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
